Venture Valuation/Biotechgate Announces Participation in Biotech Showcase, the J.P. Morgan 41st Annual Healthcare Conference 2024 and RESI

ZURICH, Switzerland, December 2023 – Venture Valuation/Biotechgate (the “Company”) is delighted to announce its participation at Biotech Showcase and Redefining Early Stage Investments (RESI) alongside the J.P. Morgan 41st Annual Healthcare Conference 2024.

During the aforementioned events, the Company team will conduct one-to-one meetings discussing their independent valuation services, life sciences database, and quarterly partnering events. Their team of experts will be available for discussions and to provide insights into solutions for the ever-evolving biotech landscape. Registered attendees can schedule a one-on-one meeting with the Company’s delegates using the conference portals. Alternatively, get in touch at to arrange a meeting.

About Venture Valuation:

Venture Valuation was founded in 1999 based on profound research work by the founder and CEO, Dr. Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne (EPFL). The company has remained true to its mission: the independent assessment and valuation of companies, products and assets.

The focus lies on technology companies in fast-growing markets and industries including pharmaceuticals, biotechnology (Biotech), medical technology (MedTech), nanotechnology, renewable energies (cleantech) and information technology (IT) / computer science / software. Clients include both, investors as well as finance-seeking companies themselves, and are domiciled on almost all continents.  Over the course of more than two decades, key strengths and expertise have been built in the life sciences industry.

About Biotechgate: Biotechgate is a leading business development and licensing database for the entire life science industry, offering a wealth of information on over 70,000 life science company profiles. Thanks to its unique data-sourcing process, the profiles include company descriptions, contact information, product pipeline information, financing rounds, and management details, making it an invaluable resource for life sciences start-ups, pharma companies, investors, and other industry professionals. Biotechgate also features 30,000 licensing deals and a clinical trials database containing over 800,000 records from registries around the world.